Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The investigators are studying two FDA-approved modalities used to treat overactive bladder
to determine if they improve overactive bladder with or without urge incontinence when used
together rather than separately, percutaneous tibial nerve stimulation (PTNS) versus PTNS and
fesoterodine fumarate.